UNICA IRIS Institutional Research Information System

CARTA, ANNAROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 831
EU - Europa 774
AS - Asia 245
AF - Africa 37
OC - Oceania 27
SA - Sud America 19
Totale 1.933
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 806
IT - Italia 375
FR - Francia 203
CN - Cina 109
GB - Regno Unito 45
DE - Germania 41
IN - India 31
AU - Australia 26
CA - Canada 22
JP - Giappone 19
HK - Hong Kong 18
NL - Olanda 16
NG - Nigeria 14
SE - Svezia 14
VN - Vietnam 14
PT - Portogallo 11
BR - Brasile 10
DK - Danimarca 10
CZ - Repubblica Ceca 9
IE - Irlanda 9
EG - Egitto 8
CH - Svizzera 7
FI - Finlandia 7
KR - Corea 7
RU - Federazione Russa 7
TR - Turchia 7
AE - Emirati Arabi Uniti 5
IL - Israele 5
IR - Iran 5
SC - Seychelles 5
TW - Taiwan 5
UA - Ucraina 5
AR - Argentina 4
CL - Cile 4
ES - Italia 4
JO - Giordania 4
SG - Singapore 4
ZA - Sudafrica 4
LU - Lussemburgo 3
BF - Burkina Faso 2
CM - Camerun 2
GR - Grecia 2
ID - Indonesia 2
IQ - Iraq 2
MX - Messico 2
QA - Qatar 2
RO - Romania 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
GE - Georgia 1
HU - Ungheria 1
LK - Sri Lanka 1
LY - Libia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
TH - Thailandia 1
UG - Uganda 1
Totale 1.933
Salva come PNG Salva come JPEG
Città #
Cagliari 213
Ashburn 144
Santa Cruz 52
Houston 49
Fairfield 48
Shanghai 36
Cambridge 27
Woodbridge 24
Seattle 23
Buffalo 22
Sydney 18
Los Angeles 16
Redmond 16
Ann Arbor 13
Henderson 13
New York 13
Saint Louis 13
San Diego 13
Council Bluffs 12
Dong Ket 12
Milan 12
Mountain View 11
Port Harcourt 10
Wilmington 10
Central 9
Chicago 9
Phoenix 9
Rome 9
Tokyo 9
Hangzhou 8
Paris 8
Columbus 7
Dallas 7
Decimomannu 7
Duncan 7
Helsinki 7
Torino 7
Beijing 6
Las Vegas 6
Ottawa 6
Perugia 6
Bengaluru 5
Boardman 5
Covilha 5
Dublin 5
Guangzhou 5
Monserrato 5
Mumbai 5
Trento 5
Wuhan 5
Amman 4
Clearwater 4
Delhi 4
Mahé 4
Naples 4
Pittsburgh 4
Toronto 4
Atlanta 3
Bloomington 3
Boston 3
Cairo 3
Copenhagen 3
Düsseldorf 3
Gainesville 3
Lausanne 3
Madison 3
Manassas 3
Melbourne 3
Muizenberg 3
Oxford 3
Randers 3
San Francisco 3
Sassari 3
Shenzhen 3
Taipei 3
Tappahannock 3
Uta 3
Vanves 3
Verona 3
Aliso Viejo 2
Amsterdam 2
Angered 2
Antalya 2
Beckenham 2
Beinasco 2
Berlin 2
Bourgoin-Jallieu 2
Boydton 2
Calgary 2
Carol Stream 2
Cedar Knolls 2
Changsha 2
Crugers 2
Denver 2
Durham 2
Erlangen 2
Florence 2
Frankfurt am Main 2
Genoa 2
Grenoble 2
Totale 1.128
Salva come PNG Salva come JPEG
Nome #
Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease, file e2f56ed8-51ee-3eaf-e053-3a05fe0a5d97 334
Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: virus-based models versus inoculation of exogenous preformed toxic species, file e2f56ed9-1de2-3eaf-e053-3a05fe0a5d97 265
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease, file e2f56eda-0146-3eaf-e053-3a05fe0a5d97 231
Microglial phagocytosis and its regulation: A therapeutic target in parkinson’s disease?, file e2f56ed7-dca6-3eaf-e053-3a05fe0a5d97 210
Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model, file e2f56ed8-b289-3eaf-e053-3a05fe0a5d97 198
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers, file e2f56ed9-8fbd-3eaf-e053-3a05fe0a5d97 139
Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson’s Disease, file e2f56ed8-dbd5-3eaf-e053-3a05fe0a5d97 119
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders, file e2f56eda-98c3-3eaf-e053-3a05fe0a5d97 113
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent, file 2df883f3-97b7-47d0-a446-92fe864dc91a 63
BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression, file 50abf18c-5b38-42de-8ac7-d6091962d2b5 57
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?, file e2f56eda-98c5-3eaf-e053-3a05fe0a5d97 57
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease, file e2f56eda-35ae-3eaf-e053-3a05fe0a5d97 26
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex, file c7019803-f504-490f-b60c-68ce13eb7330 18
Microglial phenotypes in Parkinson's disease and animal models of the disease, file e2f56ed5-a009-3eaf-e053-3a05fe0a5d97 18
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex, file f427bc96-de82-422f-b432-ca75c4ae6f0f 17
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2, file 9c2ad87b-fbe7-4bcd-9fcb-94b603a23110 14
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease, file e2f56ed8-a032-3eaf-e053-3a05fe0a5d97 14
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease, file a086d97f-7977-485f-99ee-4d24a21cc7d1 13
null, file e2f56ed5-9563-3eaf-e053-3a05fe0a5d97 12
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders, file e2f56ed8-df59-3eaf-e053-3a05fe0a5d97 10
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa, file 8851ed3d-31d0-4c2e-897d-ce0e1291e090 8
Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson’s disease, file e2f56ed3-89c0-3eaf-e053-3a05fe0a5d97 5
L-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?, file e2f56ed6-0594-3eaf-e053-3a05fe0a5d97 5
Role of Adenosine in the basal Ganglia, file e2f56ed6-0676-3eaf-e053-3a05fe0a5d97 5
Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice, file e2f56ed6-0789-3eaf-e053-3a05fe0a5d97 5
Modulating microglia activity with PPAR-gamma agonists: a promising therapy for Parkinson's disease?, file e2f56ed3-9357-3eaf-e053-3a05fe0a5d97 4
Nematicidal activity of 2-thiophenecarboxaldehyde and methylisothiocyanate from caper (Capparis spinosa) against Meloidogyne incognita, file e2f56ed3-c86d-3eaf-e053-3a05fe0a5d97 4
The 6-hydroxydopamine model of Parkinson's disease, file e2f56ed4-11b8-3eaf-e053-3a05fe0a5d97 4
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats, file e2f56ed6-d5bc-3eaf-e053-3a05fe0a5d97 4
PPAR-γ: Therapeutic Prospects in Parkinson's Disease., file e2f56ed3-8d98-3eaf-e053-3a05fe0a5d97 3
The interrelationship between dopamine and noradrenaline in the prefrontal cortex: From physiology to therapy, file e2f56ed3-9a1f-3eaf-e053-3a05fe0a5d97 3
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?, file e2f56ed3-c310-3eaf-e053-3a05fe0a5d97 3
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat, file e2f56ed4-5a57-3eaf-e053-3a05fe0a5d97 3
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease, file e2f56ed4-75fa-3eaf-e053-3a05fe0a5d97 3
null, file e2f56ed5-964b-3eaf-e053-3a05fe0a5d97 3
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications, file e2f56ed9-505b-3eaf-e053-3a05fe0a5d97 3
Microglial phenotypes in Parkinson's disease and animal models of the disease, file e2f56ed9-d54a-3eaf-e053-3a05fe0a5d97 3
null, file e2f56ed3-ba63-3eaf-e053-3a05fe0a5d97 2
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. , file e2f56ed3-bd99-3eaf-e053-3a05fe0a5d97 2
Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats, file e2f56ed9-d7cd-3eaf-e053-3a05fe0a5d97 2
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease , file e2f56ed3-8bca-3eaf-e053-3a05fe0a5d97 1
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease, file e2f56ed3-a6c9-3eaf-e053-3a05fe0a5d97 1
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease, file e2f56ed3-a6ca-3eaf-e053-3a05fe0a5d97 1
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress, file e2f56ed3-bb25-3eaf-e053-3a05fe0a5d97 1
null, file e2f56ed6-0a37-3eaf-e053-3a05fe0a5d97 1
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function, file e2f56ed8-2cdf-3eaf-e053-3a05fe0a5d97 1
The MPTP/probenecid model of progressive Parkinson's disease, file e2f56ed8-cc37-3eaf-e053-3a05fe0a5d97 1
Can pioglitazone be potentially useful therapeutically in treating patients with Covid-19?, file e2f56ed9-28b3-3eaf-e053-3a05fe0a5d97 1
Totale 2.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 0 6
2019/2020169 5 5 34 13 13 13 18 13 17 16 15 7
2020/2021322 20 12 11 13 46 59 29 18 27 18 30 39
2021/2022376 30 17 23 31 45 31 19 21 33 28 58 40
2022/2023494 31 22 70 31 27 38 56 27 56 54 47 35
2023/2024592 49 47 54 51 54 63 135 46 33 55 5 0
Totale 2.010